• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术后血清内皮素水平与冠状动脉旁路手术后去甲肾上腺素支持时间有关。

Postoperative serum levels of Endocan are associated with the duration of norepinephrine support after coronary artery bypass surgery.

机构信息

Department of Anaesthesiology and Critical Care Medicine, hôpital Pitié-Salpêtrière, Sorbonne University, UPMC université Paris 06, Assistance publique-Hôpitaux de Paris (AP-HP), 47-83 boulevard de l'Hôpital, 75651 Paris cedex 13, France.

Department of Anaesthesiology and Critical Care Medicine, hôpital Pitié-Salpêtrière, Sorbonne University, UPMC université Paris 06, Assistance publique-Hôpitaux de Paris (AP-HP), 47-83 boulevard de l'Hôpital, 75651 Paris cedex 13, France.

出版信息

Anaesth Crit Care Pain Med. 2018 Dec;37(6):565-570. doi: 10.1016/j.accpm.2018.02.013. Epub 2018 Feb 21.

DOI:10.1016/j.accpm.2018.02.013
PMID:29476941
Abstract

BACKGROUND

Cardiopulmonary bypass (CPB) is associated with a systemic inflammatory response and an endothelial dysfunction, whose qualitative assessment appears to be a major issue. Endocan (ESM-1, endothelial cell specific molecule-1) is a protein preferentially expressed by the endothelium and previously associated with prognosis of septic shock or acute respiratory distress syndrome. In this pilot study, we investigated the kinetic of Endocan in planned coronary artery bypass grafting (CABG) surgery with CPB.

PATIENTS AND METHODS

We conducted an observational, prospective, mono centre study. All adult patients with left systolic ejection fraction>50%, undergoing planned on-pump CABG, were screened for inclusion. A written informed consent was obtained. Measurements and main results Serum Endocan concentrations were respectively 2.4 [2.1-3.0] ng. mL, 10.4 [7.4-13.9] ng.mL, 5.7 [4.4-8.2] ng.mL, and 5.4 [4.1-7.5] ng.mL at day 0, day 1, day 3 and day 5. Endocan concentrations increased at day 1, day 3, and day 5 in comparison with preoperative concentration (P<0.001). In the multivariate analysis, age (P=0.002), history of acute coronary syndrome (P=0.024) and the catecholamine-free days at day 28 (P=0.007) were associated to the increase of perioperative Endocan concentrations.

CONCLUSION

Serum Endocan concentration increases after CABG surgery with CPB until day 1. The norepinephrine support increases the risk of Endocan release, suggesting a relationship between the kinetic of Endocan and the vasoplegic syndrome. At day 3, Endocan concentration decreases slowly but is not normalised at day 5. Further studies should investigate the prognostic value of the magnitude of postoperative Endocan concentration after cardiac surgery.

摘要

背景

体外循环(CPB)与全身炎症反应和内皮功能障碍有关,其定性评估似乎是一个主要问题。内皮细胞特异性分子-1(ESM-1,内皮细胞特异性分子-1)是一种优先由内皮细胞表达的蛋白质,先前与脓毒症休克或急性呼吸窘迫综合征的预后相关。在这项初步研究中,我们研究了 CPB 计划冠状动脉旁路移植术(CABG)中内参的动力学。

患者和方法

我们进行了一项观察性、前瞻性、单中心研究。所有左收缩射血分数>50%、计划行体外循环 CABG 的成年患者均进行了纳入筛选。获得书面知情同意。测量和主要结果血清内参浓度分别为 2.4[2.1-3.0]ng.ml、10.4[7.4-13.9]ng.ml、5.7[4.4-8.2]ng.ml 和 5.4[4.1-7.5]ng.ml 于第 0 天、第 1 天、第 3 天和第 5 天。与术前浓度相比,第 1 天、第 3 天和第 5 天内参浓度升高(P<0.001)。多变量分析显示,年龄(P=0.002)、急性冠状动脉综合征史(P=0.024)和第 28 天去甲肾上腺素无支持天数(P=0.007)与围手术期内参浓度升高相关。

结论

CPB 后 CABG 手术血清内参浓度升高至第 1 天。去甲肾上腺素支持增加了内参释放的风险,提示内参动力学与血管扩张性综合征之间存在关系。第 3 天,内参浓度缓慢下降,但第 5 天未恢复正常。进一步的研究应探讨心脏手术后术后内参浓度的幅度对预后的价值。

相似文献

1
Postoperative serum levels of Endocan are associated with the duration of norepinephrine support after coronary artery bypass surgery.术后血清内皮素水平与冠状动脉旁路手术后去甲肾上腺素支持时间有关。
Anaesth Crit Care Pain Med. 2018 Dec;37(6):565-570. doi: 10.1016/j.accpm.2018.02.013. Epub 2018 Feb 21.
2
Perioperative kinetics of endocan in patients undergoing cardiac surgery with and without cardiopulmonary bypass.接受有或无体外循环心脏手术患者围手术期内脂素的动力学
Cytokine. 2016 Jul;83:8-12. doi: 10.1016/j.cyto.2016.03.006. Epub 2016 Mar 19.
3
Endocan: a biomarker predicting successful reperfusion after coronary artery by-pass surgery of acute coronary syndrome patients.内皮细胞蛋白 C 受体:急性冠脉综合征患者冠状动脉旁路移植术后再灌注成功的预测生物标志物。
Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):338-342. doi: 10.26355/eurrev_201901_16781.
4
Kinetics of endocan in patients undergoing cardiac surgery with and without cardiopulmonary bypass.心脏手术中体外循环与非体外循环患者的内皮细胞蛋白 C 受体动力学。
Cytokine. 2018 Oct;110:328-332. doi: 10.1016/j.cyto.2018.03.040. Epub 2018 Apr 4.
5
Vitamin D and Postoperative Vasopressor Use in Cardiopulmonary Bypass.维生素D与体外循环术后血管升压药的使用
Clin Appl Thromb Hemost. 2018 Nov;24(8):1322-1326. doi: 10.1177/1076029618772357. Epub 2018 May 6.
6
Factors associated with vasoplegic shock in the postoperative period of cardiac surgery and influence on morbidity and mortality of the use of arginine vasopressin as rescue therapy.心脏手术后并发血管扩张性休克的相关因素及精氨酸加压素作为抢救治疗的应用对发病率和死亡率的影响。
Med Intensiva (Engl Ed). 2024 Jul;48(7):392-402. doi: 10.1016/j.medine.2024.04.003. Epub 2024 May 1.
7
Endothelial cell-specific molecule-1/endocan: Diagnostic and prognostic value in patients suffering from severe sepsis and septic shock.内皮细胞特异性分子-1/内皮糖蛋白:对严重脓毒症和脓毒性休克患者的诊断及预后价值
J Crit Care. 2016 Feb;31(1):68-75. doi: 10.1016/j.jcrc.2015.09.019. Epub 2015 Sep 25.
8
Human Endothelial Cell-Specific Molecule-1 (Endocan) and Coronary Artery Disease and Microvascular Angina.人内皮细胞特异性分子-1(内皮糖蛋白)与冠状动脉疾病和微血管性心绞痛
Angiology. 2016 Oct;67(9):846-53. doi: 10.1177/0003319715625827. Epub 2016 Jan 6.
9
Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study.血清内脂素水平与冠状动脉疾病严重程度:一项初步研究。
Angiology. 2015 Sep;66(8):727-31. doi: 10.1177/0003319714548870. Epub 2014 Aug 28.
10
Evaluation of endothelial biomarkers as predictors of organ failures in septic shock patients.评估内皮生物标志物作为脓毒症休克患者器官功能衰竭预测指标的作用。
Cytokine. 2015 Jun;73(2):213-8. doi: 10.1016/j.cyto.2015.02.013. Epub 2015 Mar 17.

引用本文的文献

1
Ascorbic acid and microcirculation in cardiothoracic surgery: a pilot feasibility trial and matched cohort study.抗坏血酸与心胸外科手术中的微循环:一项初步可行性试验及匹配队列研究。
J Cardiothorac Surg. 2025 May 22;20(1):234. doi: 10.1186/s13019-025-03486-8.
2
Impact of early postoperative blood glucose variability on serum endocan level in cardiac surgery patients: a sub study of the ENDOLUNG observational study.心脏手术患者术后早期血糖变异性对血清内皮素水平的影响:ENDOLUNG 观察性研究的子研究。
Cardiovasc Diabetol. 2023 Aug 24;22(1):221. doi: 10.1186/s12933-023-01959-5.
3
The association of catestatin and endocan with the effects of cardiac shock wave therapy: Biomarker sub-study of the randomized, sham procedure-controlled trial.
卡替他汀和内皮糖蛋白与心脏冲击波疗法效果的关联:随机、假手术对照试验的生物标志物子研究
Front Cardiovasc Med. 2023 Feb 23;10:1004574. doi: 10.3389/fcvm.2023.1004574. eCollection 2023.
4
Endothelitis profile in acute heart failure and cardiogenic shock patients: Endocan as a potential novel biomarker and putative therapeutic target.急性心力衰竭和心源性休克患者的内皮炎症特征:内皮糖蛋白作为一种潜在的新型生物标志物和假定的治疗靶点。
Front Physiol. 2022 Aug 11;13:965611. doi: 10.3389/fphys.2022.965611. eCollection 2022.
5
Endocan, sepsis, pneumonia, and acute respiratory distress syndrome.内消蛋白、脓毒症、肺炎和急性呼吸窘迫综合征。
Crit Care. 2018 Oct 26;22(1):280. doi: 10.1186/s13054-018-2222-7.